$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Metabolism, Transport and Drug-Drug Interactions of Silymarin 원문보기

Molecules a journal of synthetic chemistry and natural product chemistry, v.24 no.20, 2019년, pp.3693 -   

Xie, ,  Zhang, ,  Zhang, ,  Yuan,

Abstract AI-Helper 아이콘AI-Helper

Silymarin, the extract of milk thistle, and its major active flavonolignan silybin, are common products widely used in the phytotherapy of liver diseases. They also have promising effects in protecting the pancreas, kidney, myocardium, and the central nervous system. However, inconsistent results ar...

참고문헌 (75)

  1. Bijak, Michal. Silybin, a Major Bioactive Component of Milk Thistle ( Silybum marianum L. Gaernt.)—Chemistry, Bioavailability, and Metabolism. Molecules a journal of synthetic chemistry and natural product chemistry, vol.22, no.11, 1942-.

  2. Rainone Milk thistle Am. Fam. Physician 2005 72 1285 

  3. Lee, J.I., Narayan, M., Barrett, J.S.. Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, vol.845, no.1, 95-103.

  4. Han, Y.H., Lou, H.X., Ren, D.M., Sun, L.R., Ma, B., Ji, M.. Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process. Journal of pharmaceutical and biomedical analysis, vol.34, no.5, 1071-1078.

  5. Kim, Nam-Cheol, Graf, Tyler N., Sparacino, Charles M., Wani, Mansukh C., Wall, Monroe E.. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). Organic & biomolecular chemistry, vol.1, no.10, 1684-1689.

  6. Federico, Alessandro, Dallio, Marcello, Loguercio, Carmelina. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules a journal of synthetic chemistry and natural product chemistry, vol.22, no.2, 191-.

  7. Abenavoli, Ludovico, Izzo, Angelo A., Milić, Natasa, Cicala, Carla, Santini, Antonello, Capasso, Raffaele. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy research : PTR, vol.32, no.11, 2202-2213.

  8. Surai, Peter F.. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants, vol.4, no.1, 204-247.

  9. Soleimani, Vahid, Delghandi, Parisa Sadat, Moallem, Seyed Adel, Karimi, Gholamreza. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytotherapy research : PTR, vol.33, no.6, 1627-1638.

  10. Matsuda, Takeru, Ferreri, Kevin, Todorov, Ivan, Kuroda, Yoshikazu, Smith, Craig V., Kandeel, Fouad, Mullen, Yoko. Silymarin Protects Pancreatic β-Cells against Cytokine-Mediated Toxicity: Implication of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and Activator of Transcription Pathways. Endocrinology, vol.146, no.1, 175-185.

  11. Fallahzadeh, M.K., Dormanesh, B., Sagheb, M.M., Roozbeh, J., Vessal, G., Pakfetrat, M., Daneshbod, Y., Kamali-Sarvestani, E., Lankarani, K.B.. Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, vol.60, no.6, 896-903.

  12. Raina, Komal, Rajamanickam, Subapriya, Singh, Rana P., Deep, Gagan, Chittezhath, Manesh, Agarwal, Rajesh. Stage-Specific Inhibitory Effects and Associated Mechanisms of Silibinin on Tumor Progression and Metastasis in Transgenic Adenocarcinoma of the Mouse Prostate Model. Cancer research : the official organ of the American Association for Cancer Research, Inc, vol.68, no.16, 6822-6830.

  13. Chakrabarti, Mrinmay, Ray, Swapan K.. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Apoptosis : an international journal on programmed cell death, vol.21, no.3, 312-328.

  14. Jahanafrooz, Zohreh, Motamed, Nasrin, Rinner, Beate, Mokhtarzadeh, Ahad, Baradaran, Behzad. Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life sciences, vol.213, 236-247.

  15. Sciacca, Michele. F. M., Romanucci, Valeria, Zarrelli, Armando, Monaco, Irene, Lolicato, Fabio, Spinella, Natalia, Galati, Clelia, Grasso, Giuseppe, D’Urso, Luisa, Romeo, Margherita, Diomede, Luisa, Salmona, Mario, Bongiorno, Corrado, Di Fabio, Giovanni, La Rosa, Carmelo, Milardi, Danilo. Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry. ACS chemical neuroscience, vol.8, no.8, 1767-1778.

  16. Sciacca, Michele F.M., Tempra, Carmelo, Scollo, Federica, Milardi, Danilo, La Rosa, Carmelo. Amyloid growth and membrane damage: Current themes and emerging perspectives from theory and experiments on Aβ and hIAPP. Biochimica et biophysica acta, Biomembranes, vol.1860, no.9, 1625-1638.

  17. Fried, Michael W, Navarro, Victor J, Afdhal, Nezam, Belle, Steven H, Wahed, Abdus S, Hawke, Roy L, Doo, Edward, Meyers, Catherine M, Reddy, K Rajender. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.. JAMA : the journal of the American Medical Association, vol.308, no.3, 274-282.

  18. Loguercio, Carmela, Festi, Davide. Silybin and the liver: from basic research to clinical practice.. World journal of gastroenterology : WJG, vol.17, no.18, 2288-2301.

  19. Xu, Peng, Zhou, Hua, Li, Ya-Zhuo, Yuan, Zhong-Wen, Liu, Chang-Xiao, Liu, Liang, Xie, Ying. Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2. Frontiers in pharmacology, vol.9, 1115-.

  20. Javed Reassessing bioavailability of silymarin Altern. Med. Rev. A J. Clin. Ther. 2011 16 239 

  21. Wen, Zhiming, Dumas, Todd E., Schrieber, Sarah J., Hawke, Roy L., Fried, Michael W., Smith, Philip C.. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract. Drug metabolism and disposition: the biological fate of chemicals, vol.36, no.1, 65-72.

  22. Schrieber, Sarah J., Wen, Zhiming, Vourvahis, Manoli, Smith, Philip C., Fried, Michael W., Kashuba, Angela D. M., Hawke, Roy L.. The Pharmacokinetics of Silymarin Is Altered in Patients with Hepatitis C Virus and Nonalcoholic Fatty Liver Disease and Correlates with Plasma Caspase-3/7 Activity. Drug metabolism and disposition: the biological fate of chemicals, vol.36, no.9, 1909-1916.

  23. Yuan, Zhong-Wen, Li, Ya-Zhuo, Liu, Zhong-Qiu, Feng, Sen-ling, Zhou, Hua, Liu, Chang-Xiao, Liu, Liang, Xie, Ying. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological research : the official journal of the Italian Pharmacological Society, vol.128, 153-166.

  24. Kren, Vladimír, Marhol, Petr, Purchartová, Katerina, Gabrielová, Eva, Modriansky, Martin. Biotransformation of Silybin and its Congeners. Current drug metabolism, vol.14, no.10, 1009-1021.

  25. Jančová, Petra, Anzenbacherová, Eva, Papoušková, Barbora, Lemr, Karel, Lužná, Pavla, Veinlichová, Alena, Anzenbacher, Pavel, Šimánek, Vilím. Silybin Is Metabolized by Cytochrome P450 2C8 in Vitro. Drug metabolism and disposition: the biological fate of chemicals, vol.35, no.11, 2035-2039.

  26. Gunaratna, Chandrani, Zhang, Tianyi. Application of liquid chromatography–electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, vol.794, no.2, 303-310.

  27. Janč?ová찼, Petra, Š?iller, Michal, Anzenbacherová찼, Eva, Kř?en, Vladimí챠r, Anzenbacher, Pavel, Š?imá찼nek, Vilí챠m. Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases. Xenobiotica, vol.41, no.9, 743-751.

  28. Hoh, C. S. L., Boocock, D. J., Marczylo, T. H., Brown, V. A., Cai, H., Steward, W. P., Berry, D. P., Gescher, A. J.. Quantitation of Silibinin, a Putative Cancer Chemopreventive Agent Derived from Milk Thistle (Silybum marianum), in Human Plasma by High-Performance Liquid Chromatography and Identification of Possible Metabolites. Journal of agricultural and food chemistry, vol.55, no.7, 2532-2535.

  29. Hoh, Carmen, Boocock, David, Marczylo, Tim, Singh, Rajinder, Berry, David P., Dennison, Ashley R., Hemingway, David, Miller, Andrew, West, Kevin, Euden, Stephanie, Garcea, Giuseppe, Farmer, Peter B., Steward, William P., Gescher, Andreas J.. Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.12, no.9, 2944-2950.

  30. Xie, Ying, Miranda, Sonia R., Hoskins, Janelle M., Hawke, Roy L.. Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD. Molecules a journal of synthetic chemistry and natural product chemistry, vol.22, no.1, 142-.

  31. Lorenz Pharmacokinetic studies with silymarin in human serum and bile Methods Find. Exp. Clin. Pharm. 1984 6 655 

  32. Wu, J.W., Lin, L.C., Hung, S.C., Chi, C.W., Tsai, T.H.. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. Journal of pharmaceutical and biomedical analysis, vol.45, no.4, 635-641.

  33. Miranda, Sonia R., Lee, Jin Kyung, Brouwer, Kim L. R., Wen, Zhiming, Smith, Philip C., Hawke, Roy L.. Hepatic Metabolism and Biliary Excretion of Silymarin Flavonolignans in Isolated Perfused Rat Livers: Role of Multidrug Resistance-Associated Protein 2 (Abcc2). Drug metabolism and disposition: the biological fate of chemicals, vol.36, no.11, 2219-2226.

  34. Bi, Xiaoli, Yuan, Zhongwen, Qu, Biao, Zhou, Hua, Liu, Zhongqiu, Xie, Ying. Piperine enhances the bioavailability of silybin via inhibition of efflux transporters BCRP and MRP2. Phytomedicine : international journal of phytotherapy and phytopharmacology, vol.54, 98-108.

  35. Kesarwani, K., Gupta, R.. Bioavailability enhancers of herbal origin: An overview. Asian Pacific journal of tropical biomedicine, vol.3, no.4, 253-266.

  36. Hung, Wei-Lun, Chang, Wei-Shan, Lu, Wen-Chien, Wei, Guor-Jien, Wang, Yu, Ho, Chi-Tang, Hwang, Lucy Sun. Pharmacokinetics, bioavailability, tissue distribution and excretion of tangeretin in rat. Journal of food and drug analysis, vol.26, no.2, 849-857.

  37. Lee, Sang Hoon, Kim, Hyeon Young, Back, Seung Yun, Han, Hyo-Kyung. Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. Expert opinion on drug metabolism & toxicology, vol.14, no.1, 43-57.

  38. Woo, A.Y.H., Cheng, C.H.K., Waye, M.M.Y.. Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism. Cardiovascular research, vol.65, no.1, 244-253.

  39. Bie, Beibei, Sun, Jin, Guo, Ying, Li, Jun, Jiang, Wei, Yang, Jun, Huang, Chen, Li, Zongfang. Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, vol.93, 1285-1291.

  40. Lai, Miao-Ying, Hsiu, Su-Lan, Tsai, Shang-Yuan, Hou, Yu-Chi, Chao, Pei-Dawn Lee. Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. Journal of pharmacy and pharmacology, vol.55, no.2, 205-209.

  41. Zhang, Li, Lin, Ge, Zuo, Zhong. Involvement of UDP-Glucuronosyltransferases in the Extensive Liver and Intestinal First-Pass Metabolism of Flavonoid Baicalein. Pharmaceutical research, vol.24, no.1, 81-.

  42. Beckmann-Knopp, Svane, Rietbrock, Stephan, Weyhenmeyer, Roland, Böcker, Ronald H., Beckurts, K. Tobias, Lang, Werner, Hunz, Miriam, Fuhr, Uwe. Inhibitory Effects of Silibinin on Cytochrome P-450 Enzymes in Human Liver Microsomes. Pharmacology & toxicology, vol.86, no.6, 250-256.

  43. Wu, Jhy-Wen, Lin, Lie-Chwen, Tsai, Tung-Hu. Drug–drug interactions of silymarin on the perspective of pharmacokinetics. Journal of ethnopharmacology, vol.121, no.2, 185-193.

  44. Zuber, Roman, Modrianský, Martin, Dvořák, Zdeněk, Rohovský, Petr, Ulrichová, Jitka, Šimánek, Vilím, Anzenbacher, Pavel. Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytotherapy research : PTR, vol.16, no.7, 632-638.

  45. Gurley, Bill J., Fifer, Espero Kim, Gardner, Zoë. Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance. Planta medica, vol.78, no.13, 1490-1514.

  46. Brantley, Scott J., Oberlies, Nicholas H., Kroll, David J., Paine, Mary F.. Two Flavonolignans from Milk Thistle (Silybum marianum) Inhibit CYP2C9-Mediated Warfarin Metabolism at Clinically Achievable Concentrations. The Journal of pharmacology and experimental therapeutics, vol.332, no.3, 1081-1087.

  47. Budzinski, Jason W., Trudeau, Vance L., Drouin, Cathy E., Panahi, Mitra, Arnason, J. Thor, Foster, Brian C.. Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal productsThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products.. Canadian journal of physiology and pharmacology, vol.85, no.9, 966-978.

  48. Kosina, Pavel, Maurel, Patrick, Ulrichová, Jitka, Dvořák, Zdeněk. Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytes. Journal of biochemical and molecular toxicology, vol.19, no.3, 149-153.

  49. Leber Influence of silymarin on drug metabolizing enzymes in rat and man Arzneimittelforschung 1976 26 1603 

  50. Piscitelli, Stephen C., Formentini, Elizabeth, Burstein, Aaron H., Alfaro, Raul, Jagannatha, Shyla, Falloon, Judith. Effect of Milk Thistle on the Pharmacokinetics of Indinavir in Healthy Volunteers. Pharmacotherapy, vol.22, no.5, 551-556.

  51. Mills, Edward, Wilson, Kumanan, Clarke, Mike, Foster, Brian, Walker, Scott, Rachlis, Beth, DeGroot, Nick, Montori, Victor M., Gold, Wayne, Phillips, Elizabeth, Myers, Stephen, Gallicano, Keith. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. European journal of clinical pharmacology, vol.61, no.1, 1-7.

  52. Gurley In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto Clin. Pharm. 2004 76 428 

  53. Gurley, Bill, Hubbard, Martha A., Williams, D. Keith, Thaden, John, Tong, Yudong, Gentry, W. Brooks, Breen, Philip, Carrier, Danielle J., Cheboyina, Shreekar. Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin. The Journal of clinical pharmacology, vol.46, no.2, 201-213.

  54. van Erp, Nielka P.H., Baker, Sharyn D., Zhao, Ming, Rudek, Michelle A., Guchelaar, Henk-Jan, Nortier, Johan W.R., Sparreboom, Alex, Gelderblom, Hans. Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan. Clinical Cancer research : an official journal of the American Association for Cancer Research, vol.11, no.21, 7800-7806.

  55. Rao,, B. Nageshwar, Srinivas,, Maddi, Kumar,, Y. Shravan, Rao,, Y. Madhusudan. EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS. Drug metabolism and drug interactions, vol.22, no.2, 175-186.

  56. Gurley, Bill J., Swain, Ashley, Hubbard, Martha A., Williams, D. Keith, Barone, Gary, Hartsfield, Faith, Tong, Yudong, Carrier, Danielle J., Cheboyina, Shreekar, Battu, Sunil K.. Clinical assessment of CYP2D6-mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Molecular nutrition & food research, vol.52, no.7, 755-763.

  57. DiCenzo, Robert, Shelton, Mark, Jordan, Kelly, Koval, Christine, Forrest, Alan, Reichman, Richard, Morse, Gene. Coadministration of Milk Thistle and Indinavir in Healthy Subjects. Pharmacotherapy, vol.23, no.7, 866-870.

  58. Rajnarayana, Kandhagatla, Reddy, Mada Sripal, Vidyasagar, Jenugu, Krishna, Devarakonda R.. Study on the Influence of Silymarin Pretreatment on Metabolism and Disposition of Metronidazole. Arzneimittel Forschung = Drug research, vol.54, no.2, 109-113.

  59. Gurley, Bill J., Barone, Gary W., Williams, D. Keith, Carrier, Julie, Breen, Philip, Yates, C. Ryan, Song, Peng-fei, Hubbard, Martha A., Tong, Yudong, Cheboyina, Sreekhar. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS. Drug metabolism and disposition: the biological fate of chemicals, vol.34, no.1, 69-74.

  60. Fuhr, U., Beckmann-Knopp, S., Jetter, A., Luck, H., Mengs, U.. The Effect of Silymarin on Oral Nifedipine Pharmacokinetics. Planta medica, vol.73, no.14, 1429-1435.

  61. Deng, Jian Wei, Shon, Ji-Hong, Shin, Ho-Jung, Park, Soo-Jin, Yeo, Chang-Woo, Zhou, Hong-Hao, Song, Im-Sook, Shin, Jae-Gook. Effect of Silymarin Supplement on the Pharmacokinetics of Rosuvastatin. Pharmaceutical research, vol.25, no.8, 1807-1814.

  62. Han, Y., Guo, D., Chen, Y., Tan, Z.-R., Zhou, H.-H.. Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers. Xenobiotica, vol.39, no.9, 694-699.

  63. Han, Yang, Guo, Dong, Chen, Yao, Chen, Yu, Tan, Zhi-Rong, Zhou, Hong-Hao. Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers. European journal of clinical pharmacology, vol.65, no.6, 585-591.

  64. Moltó, José, Valle, Marta, Miranda, Cristina, Cedeño, Samandhy, Negredo, Eugenia, Clotet, Bonaventura. Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients. Antimicrobial agents and chemotherapy, vol.56, no.6, 2837-2841.

  65. Yamsani, Shravan Kumar, Yamsani, Madhusudan Rao. Effect of silymarin pretreatment on the bioavailability of domperidone in healthy human volunteers. Drug metabolism and drug interactions, vol.29, no.4, 261-267.

  66. Kawaguchi-Suzuki, Marina, Frye, Reginald F., Zhu, Hao-Jie, Brinda, Bryan J., Chavin, Kenneth D., Bernstein, Hilary J., Markowitz, John S.. The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity. Drug metabolism and disposition: the biological fate of chemicals, vol.42, no.10, 1611-1616.

  67. Voruganti, Swathi, Yamsani, Shravan Kumar, Yamsani, Madhusudan Rao. Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits. European journal of drug metabolism and pharmacokinetics, vol.39, no.4, 277-281.

  68. Pan, Pei‐Pei, Wang, Jun, Luo, Jun, Wang, Shuang‐Hu, Zhou, Yun‐Fang, Chen, Sai‐Zhen, Du, Zhou. Silibinin affects the pharmacokinetics of methadone in rats. Drug testing and analysis, vol.10, no.3, 557-561.

  69. Venkataramanan Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures Drug Metab. Dispos. 2000 28 1270 

  70. Sridar, Chitra, Goosen, Theunis C., Kent, Ute M., Williams, J. Andrew, Hollenberg, Paul F.. SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES. Drug metabolism and disposition: the biological fate of chemicals, vol.32, no.6, 587-594.

  71. Köck, Kathleen, Xie, Ying, Hawke, Roy L., Oberlies, Nicholas H., Brouwer, Kim L. R.. Interaction of Silymarin Flavonolignans with Organic Anion-Transporting Polypeptides. Drug metabolism and disposition: the biological fate of chemicals, vol.41, no.5, 958-965.

  72. Nguyen, Hang, Zhang, Shuzhong, Morris, Marilyn E.. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, vol.92, no.2, 250-257.

  73. Hussain Silibinin improves the cytotoxicity of methotrexate in chemo resistant human rhabdomyosarcoma cell lines Saudi Med. J. 2013 34 1145 

  74. Wang, L., Collins, C., Kelly, E. J., Chu, X., Ray, A. S., Salphati, L., Xiao, G., Lee, C., Lai, Y., Liao, M., Mathias, A., Evers, R., Humphreys, W., Hop, C. E. C. A., Kumer, S. C., Unadkat, J. D.. Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics. Drug metabolism and disposition: the biological fate of chemicals, vol.44, no.11, 1752-1758.

  75. Wu, Jhy-Wen, Tsai, Tung-Hu. Effect of Silibinin on the Pharmacokinetics of Pyrazinamide and Pyrazinoic Acid in Rats. Drug metabolism and disposition: the biological fate of chemicals, vol.35, no.9, 1603-1610.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로